Botulinum Toxin Type B for Glabellar Wrinkles: A Prospective Open-Label Response Study
- 1 September 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 28 (9) , 817-821
- https://doi.org/10.1046/j.1524-4725.2002.02037.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Toxins 99, New Information About the Botulinum NeurotoxinsDermatologic Surgery, 2000
- Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystoniaNeurology, 1999
- Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–responsive cervical dystoniaNeurology, 1999
- Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystoniaNeurology, 1997
- Contemporary Management of the Aging Brow and ForeheadThe Laryngoscope, 1997
- Botulinum A exotoxin for glabellar folds: A double-blind, placebo-controlled study with an electromyographic injection techniqueJournal of the American Academy of Dermatology, 1996
- Botulinum A exotoxin use in clinical dermatologyJournal of the American Academy of Dermatology, 1996
- The Use of Botulinum A Toxin to Ameliorate Facial Kinetic Frown LinesOphthalmology, 1996
- Treatment of Glabellar Frown Lines with C. Botulinum‐A ExotoxinThe Journal of Dermatologic Surgery and Oncology, 1992
- Glabellar Frown LinesPlastic and Reconstructive Surgery, 1990